A STUDY COMPARING PROPOFOL,KETOFOL AND KETOFOL WITH DEXMEDETOMIDINE FOR INDUCING ANAESTHESIA IN ELECTRO CONVULSIVE THERAPY
Phase 4
- Conditions
- Health Condition 1: F323- Major depressive disorder, singleepisode, severe with psychotic featuresHealth Condition 2: F39- Unspecified mood [affective] disorder
- Registration Number
- CTRI/2023/04/051890
- Lead Sponsor
- MGM MEDICAL COLLEGE AND HOSPITAL AURANGABAD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with American society of Anaesthesiology (ASA) physical status I and II
2.Patients of both sexes between the ages of 18 and 65 years.
Exclusion Criteria
1.Patient on chronic opiate use such as tramadol
2.Pregnant females and lactating mothers.
3.Known allergies to the study drugs
4.Patients with hypertension, IHD and heart disease
5.Contraindications to ECT such as intracranial hypertension, previous fractures, glaucoma, cerebrovascular malformation, presence of a pacemaker.
6 Patient on Beta-blockers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A COMPARATIVE STUDY OF EFFECTIVENESS OF PROPOFOL, KETOFOL AND KETOFOL WITH DEXMEDETOMIDINE AS INDUCTION AGENT FOR ELECTROCONVULSIVE THERAPY <br/ ><br>Timepoint: A COMPARATIVE STUDY OF EFFECTIVENESS OF PROPOFOL, KETOFOL AND KETOFOL WITH DEXMEDETOMIDINE AS INDUCTION AGENT FOR ELECTROCONVULSIVE THERAPY <br/ ><br>
- Secondary Outcome Measures
Name Time Method A COMPARATIVE STUDY OF EFFECTIVENESS OF PROPOFOL, KETOFOL AND KETOFOL WITH DEXMEDETOMIDINE AS INDUCTION AGENT FOR ELECTROCONVULSIVE THERAPY <br/ ><br>Timepoint: 1.Incidence and severity of post ECT agitation <br/ ><br>2.Incidence and severity of post ECT myalgia <br/ ><br> <br/ ><br>